These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1998942)

  • 1. High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine.
    Klegerman ME; Ujjainwala L; Zeunert P
    Cancer Lett; 1991 Feb; 56(2):137-45. PubMed ID: 1998942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative tumor inhibitory and stimulatory activities of BCG vaccine preparations, lots and substrains in a quantitative mouse sarcoma bioassay.
    Klegerman ME; Zeunert PL; Lajeune J; Lou Y; Groves MJ
    Anticancer Res; 1991; 11(5):1707-10. PubMed ID: 1768040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis of Mycobacterium bovis BCG organisms by murine S180 sarcoma cells.
    Devadoss PO; Klegerman ME; Groves MJ
    Cytobios; 1993; 74(296):49-58. PubMed ID: 8330487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of murine sarcoma cell adherence to polystyrene substrata by bacillus Calmette-Guérin: evidence for fibronectin-mediated direct antitumor activity of BCG.
    Klegerman ME; Zeunert PL; Lou Y; Devadoss PO; Groves MJ
    Cancer Invest; 1993; 11(6):660-6. PubMed ID: 8221198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of M.bovis BCG and M.microti on sarcoma 180 growth in mice.
    Nedvĕdová V; Sír Z; Hyncica V; Buresová M
    Neoplasma; 1978; 25(6):685-90. PubMed ID: 377109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunostimulating and immunotherapeutic effect of BCG vaccines using listerial endotoxin-like substances.
    Mára M; Průchová J; Smerák P; John C; Miková Z; Nedvĕdová V; Sir Z
    Dev Biol Stand; 1986; 58 ( Pt A)():379-87. PubMed ID: 3596044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of BCG on the growth rate of Sarcoma in normal and splenectomized mice].
    Rumi LS; García MS
    Medicina (B Aires); 1980; 40(6 Pt 1):683-7. PubMed ID: 22167702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunochemotherapy of mice S-180 ascitic tumor by combination of cyclophosphamide and BCG].
    Chiou CY; Wong YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Mar; 2(3):164-71. PubMed ID: 3482884
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of prophylactic and therapeutic administration of BCG vaccine on growth of experimental sarcoma.
    Símová J; Bubeník J
    Folia Biol (Praha); 1975; 21(5):329-33. PubMed ID: 172377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition and stimulation of the growth of Krebs-2 carcinoma by BCG vaccine.
    Kaledin VI; Kurunov YN; Serova IA
    J Natl Cancer Inst; 1977 May; 58(5):1271-7. PubMed ID: 323506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of BCG on the growth of Krebs-2 carcinoma].
    Kaledin VI; Kurunov IuN
    Vopr Onkol; 1977; 23(8):60-3. PubMed ID: 906409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E
    J Urol; 1997 Aug; 158(2):646-52. PubMed ID: 9224385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Shared antigens between BCG and tumor cells--immunotherapy with BCG for mouse tumor].
    Sasaki J; Kanda S; Sawamura D; Kamiya S; Inaba Y; Kawashima M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1432-9. PubMed ID: 4015119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition and promotion of tumor growth by BCG: evidence for stimulation of humoral enhancing factors by BCG.
    Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K
    Int J Cancer; 1978 Jan; 21(1):67-71. PubMed ID: 624600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
    Castés M; Lynch NR; Lespinats G; Orbach-Arbouys S
    Br J Cancer; 1981 Dec; 44(6):828-37. PubMed ID: 6459797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.
    Chee DO; Bodurtha AJ
    Int J Cancer; 1974 Jul; 14(1):137-43. PubMed ID: 4617706
    [No Abstract]   [Full Text] [Related]  

  • 18. Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.
    Lou Y; Klegerman ME; Muhammad A; Dai X; Groves MJ
    Anticancer Res; 1994; 14(4A):1469-75. PubMed ID: 7979173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of antibody against vascular endothelial growth factor on tumor growth].
    Wang G; Wang N; Liu T
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):163-6. PubMed ID: 10920886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
    Chassoux D; Salomon JC
    Int J Cancer; 1975 Oct; 16(4):515-25. PubMed ID: 1176205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.